Psoriasis Treatment

Anti-inflammatory therapeutical VBL VBL-201 Properties in Keystone Symposium VBL Therapeutics, a biotechnology company dedicated clinical-stage the development of novel treatments for inflammatory immune diseases and cancer, announced that the company will present preclinical data from its program Lead, VB-201, Keystone Symposium on Bioactive Lipids: Biochemistry and diseases. Eyal Breitbart, Ph.D., research vice president is scheduled to present VBL one …
Psoriasis Treatment with the XTRAC on The Balancing Act